The U.S. Food and Drug Administration's staff reviewers on Tuesday raised safety concerns that GSK's blood cancer drug Blenrep, when used in combination with other treatments, may cause eye damage in ...

In briefing documents released ahead of an Advisory Committee meeting this week, FDA staffers cited safety risks related to a combination regimen involving GSK’s (NYSE:GSK) blood cancer drug Blenrep ...

Learn the life-threatening brain blood clot signs everyone should recognize. These red flags require immediate emergency care to prevent permanent damage.

Government warns public against fake LinkedIn accounts and viral WhatsApp messages spreading false health-related claims.

The FDA has issued an alert about a potentially high-risk issue involving Abiomed’s Automated Impella Controller, which is used with the company’s blood pump systems. Abiomed, now part of ...

FDA staff flags eye safety risks for GSK's blood cancer drug By Sneha S K and Sriparna Roy July 15, 20252:56 PM PDTUpdated July 15, 2025 ...